We have previously demonstrated an association between microsatellite instability and decreased CDK2-AP1 (p12(DOC-1)) expression in human colorectal cancer (CRC) cell lines. In those same studies, induction of CDK2-AP1 expression promoted both cell cycle arrest and apoptosis. The goals of our present study were to better understand the mechanisms leading to reduced CDK2-AP1 expression in microsatellite unstable (MSI) CRC and to study further the effect of CDK2-AP1 modulation on cell proliferation and apoptosis utilizing RNA interference (RNAi) techniques. We used direct sequencing to screen for mutations of the poly (T)8 microsatellite-like region in the 3' end of the CDK2-AP1 gene in 24 CRC cell lines. We then utilized an in vitro human mismatch repair (MMR) recombinant system to assess for correction of the mutation and changes in CDK2-AP1 expression secondary to hMLH1 transfection. We also investigated the effect of CDK2-AP1 modulation in four settings: (1) native CDK2-AP1 absence, (2) endogenous CDK2-AP1 expression, (3) RNAi-induced CDK2-AP1 inhibition and (4) induced CDK2-AP1 over expression. The mutation - del T poly (T)8 - at the 3' end of the CDK2-AP1 gene was found in 3/12 (25%) of MSI CRC cell lines, but in none of the microsatellite stable samples (0/12). Interestingly, when wild-type MMR protein - MLH1 - was induced in an in vitro human recombinant system, the del T poly (T)8 mutation was reversed and CDK2-AP1 expression increased. RNAi-mediated CDK2-AP1 inhibition was associated with decreased apoptosis and increased cell proliferation in CDK2-AP1-non deficient CRC cell lines. We conclude that mutations in the microsatellite-like sequence of the CDK2-AP1 gene in MSI CRC are associated with decreased CDK2-AP1 expression. In addition, modulation of CDK2-AP1 expression in human CRC alters cell proliferation and apoptosis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/sj.onc.1208378 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
CDK2-Mediated Upregulation of TNFα as a Mechanism of Selective Cytotoxicity in Acute Leukemia.
Cancer Res
May 2021
Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota.
Article Synopsis
- Inhibitors targeting the kinases CHK1, ATR, and WEE1 are being tested clinically, but their exact mechanisms of killing cancer cells, especially in acute leukemia, are still not fully understood.
- CHK1 inhibition has been shown to trigger apoptosis in specific acute leukemia cell lines and inhibit the formation of leukemia colonies in clinical samples, linking its effects to CDK2 activation and TNFα production.
- The study identifies a novel cytotoxic pathway for these inhibitors, which could be clinically leveraged in treating acute leukemia by inducing apoptosis through a cascade involving AP1-mediated signaling.
Cathepsin L interacts with CDK2-AP1 as a potential predictor of prognosis in patients with breast cancer.
Oncol Lett
January 2020
Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.
Article Synopsis
- Cathepsin L (CTSL) is a protein that plays a role in cancer development and was studied for its effects in breast cancer.
- The researchers used different methods to see how CTSL affects the growth and survival of breast cancer cells and found that reducing CTSL slowed down cancer cell growth.
- They discovered that high levels of CTSL in breast cancer tissues were linked to better patient outcomes, suggesting that targeting CTSL could help treat breast cancer patients.
CDK2-AP1 inhibits growth of breast cancer cells by regulating cell cycle and increasing docetaxel sensitivity in vivo and in vitro.
Cancer Cell Int
December 2014
Department of Breast Surgery, Zhejiang Cancer Hospital, 38 Guangji Road, Hangzhou, 310022 China.
Background: Cell cycle regulatory pathway is a well-established pathway mainly dependent on cyclin-dependent kinases (CDKs), which are regulated positively by cyclins and negatively by cyclin-dependent kinase inhibitors(CKIs). Cyclin-dependent kinase 2 associate protein 1(CDK2-AP1) is a specific negative regulatory protein for CDK2, is important in the cancer cell cycle. However, the function of CDK2-AP1 in breast cancer remains unclear.
View Article and Find Full Text PDF[Effect of CDK2-AP1 gene over-expression on proliferation and cell cycle regulation of breast cancer cell line MCF-7].
Zhong Nan Da Xue Xue Bao Yi Xue Ban
October 2012
Department of Oncology, Central South University, Changsha, China.
Objective: To over-express cyclin-dependent kinase 2-associated protein 1 (CDK2-AP1) gene, and investigate its effect on the proliferation and cell cycle regulation in breast cancer cell line MCF-7.
Methods: CDK2-AP1 gene coding region was cloned into lentivirus vector. Lentivirus particles were infected into MCF-7 cells to upregulate the expression of CDK2-AP1 gene.
p12(CDK2-AP1) inhibits breast cancer cell proliferation and in vivo tumor growth.
J Cancer Res Clin Oncol
December 2012
Department of Oncology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, China.
Purpose: p12(CDK2-AP1) is a growth suppressor that negatively regulates cyclin-dependent kinase 2 (CDK2) activities and shows to interfere in DNA replication. Here, we aim to elucidate the role of p12(CDK2-AP1) in breast cancer progression.
Methods: Expression of p12(CDK2-AP1) protein was examined in 60 pairs of breast cancer specimens and adjacent non-tumor tissues using immunohistochemistry assay.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!